11 /100
LOW RISK
Score updated Jul 13, 2026

HLIO — Helios Technologies, Inc. Dilution Risk Tracker

Track HLIO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HLIO — Get alerts when the score changes →

As of July 13, 2026, Helios Technologies, Inc. (HLIO) has a DilutionWatch DilutionScore of 11/100, rated LOW dilution risk. Helios Technologies, Inc. has a market capitalization of $2.75B, 33.05M shares outstanding, 251 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for HLIO.
🔔 Track HLIO — Get forecast alerts →

💹 Market Data

Market Cap$2.75B
Shares Outstanding33.05M
Float32.89M
Cash$98.06M
Debt$244.80M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 5.0% shares (2026Q1 vs prior)
251 institutional holders · 35.66M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 2.95M shares
#2 BlackRock, Inc. 2.44M shares
#3 DIMENSIONAL FUND ADVISORS LP 1.62M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest943.0K
Days to Cover2.0
% of Float2.9%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for HLIO Shareholders

Helios Technologies, Inc. (HLIO) has a DilutionScore of 11/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for HLIO shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for HLIO in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for HLIO alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track HLIO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HLIO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for HLIO
📊 HLIO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HLIO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.